للبلد: ألمانيا منصة التبادل: Frankfurt القطاع: الرعاية الصحية الصناعة: التكنولوجيا الحيوية سوق الأسهم - العروض والأسعار
قائمة بجميع الأوراق المالية والأسهم مع الأسعار، والقيم السوقية، ونسبة السعر إلى الربح، والأرباح للسهم الواحد
ألمانيا (648)
- {{country.name}}
- جميع البلدان
- ألمانيا (648)
Frankfurt (648)
الرعاية الصحية (648)
- {{item.name}}
- جميع القطاعات
- الرعاية الصحية (648)
التكنولوجيا الحيوية (648)
- {{item.name}}
- جميع الصناعات
- التكنولوجيا الحيوية (648)
- شركات تصنيع الأدوية - عامة (45)
- شركات تصنيع الأدوية - متخصصة وعامة (277)
- خطط الرعاية الصحية (9)
- منشآت الرعاية الطبية (93)
- متاجر التجزئة الصيدلانية (21)
- خدمات المعلومات الصحية (81)
- الأجهزة الطبية (202)
- الأدوات والمستلزمات الطبية (106)
- التشخيص والبحث (102)
- التوزيع الطبي (22)
| الاسم الاسم | السعر السعر |
مخطط 24 ساعة% 7 أيام 24 ساعة% و7 أيام |
القيمة السوقية القيمة السوقية | الحجم حجم التداول | القاع (24 ساعة) | القمة (24 ساعة) | القيمة السوقية | نسبة السعر/الأرباح | EPS |
|---|
| الاسم الاسم | السعر السعر |
مخطط 24 ساعة% 7 أيام 24 ساعة% و7 أيام |
القيمة السوقية القيمة السوقية | الحجم حجم التداول | القاع (24 ساعة) | القمة (24 ساعة) | القيمة السوقية | نسبة السعر/الأرباح | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $3.01 3.29 USD |
-1.63
|
$12.51B 13.68B USD | $2.58K 2.82K USD | $3.01 3.29 USD | $3.1 3.39 USD | $12.51B 13.68B USD | 33.44 | $0.09 0.1 USD | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.5999 0.66 USD |
-1.41
|
$10.87B 11.88B USD | $10K 10.93K USD | $0.5899 0.65 USD | $0.5999 0.66 USD | $10.87B 11.88B USD | 60.32 | $0.01 0.01 USD | |
| CureVac N.V. 5CV.F | $4.86 5.31 USD |
+1.59
|
$1.09B 1.2B USD | $199.94K 218.57K USD | $4.62 5.05 USD | $4.86 5.31 USD | $1.09B 1.2B USD | 6.07 | $0.8 0.87 USD | |
| CStone Pharmaceuticals PH4.F | $0.51 0.55 USD |
-0.98
|
$685.32M 749.15M USD | $250 273.28 USD | $0.51 0.55 USD | $0.51 0.55 USD | $685.32M 749.15M USD | 0 | -$0.01 -0.01 USD | |
| Valneva SE AYJ.F | $2.68 2.93 USD |
-2.12
|
$462.57M 505.66M USD | $14.65K 16.01K USD | $2.68 2.93 USD | $2.71 2.96 USD | $462.57M 505.66M USD | 0 | -$0.56 -0.6 USD | |
| Ocugen, Inc. 2H51.F | $0.9899 1.08 USD |
-3.38
|
$287.94M 314.76M USD | $12.97K 14.18K USD | $0.9599 1.05 USD | $1 1.09 USD | $287.94M 314.76M USD | 0 | -$0.17 -0.1 USD | |
| Abliva AB (publ) NTP.F | $0.04 0.04 USD |
0
|
$64.47M 70.47M USD | $4K 4.37K USD | $0.02999 0.03 USD | $0.04 0.04 USD | $64.47M 70.47M USD | 0 | -$0.01 -0.01 USD | |
| Alterity Therapeutics Limited PBN.F | $0.004 0.0043 USD |
0
|
$54.98M 60.1M USD | $480K 524.7K USD | $0.004 0.0043 USD | $0.004 0.0043 USD | $54.98M 60.1M USD | 0 | $0 0 USD | |
| Defence Therapeutics Inc. DTC.F | $0.5 0.55 USD |
-5.28
|
$27.47M 30.03M USD | $7.16K 7.82K USD | $0.5 0.55 USD | $0.54 0.59 USD | $27.47M 30.03M USD | 0 | -$0.05 -0.05 USD | |
| Active Biotech AB (publ) BTPC.F | $0.02 0.02 USD |
-13.22
|
$26.78M 29.28M USD | $6K 6.56K USD | $0.02 0.02 USD | $0.02 0.02 USD | $26.78M 29.28M USD | 0 | -$0.01 -0.01 USD | |
| BioVaxys Technology Corp. 5LB.F | $0.01 0.01 USD |
0
|
$6.51M 7.12M USD | $23K 25.14K USD | $0.01 0.01 USD | $0.01 0.01 USD | $6.51M 7.12M USD | 0 | -$0.01 -0.01 USD | |
| Glow Lifetech Corp. 9DO.F | $0.02999 0.03 USD |
+56.1
|
$4.84M 5.29M USD | $5K 5.47K USD | $0.02 0.02 USD | $0.02999 0.03 USD | $4.84M 5.29M USD | 0 | -$0.02 -0.02 USD | |
| Medigene AG MDG1.F | $0.1199 0.13 USD |
+2.22
|
$1.97M 2.15M USD | $7.08K 7.74K USD | $0.11 0.12 USD | $0.1199 0.13 USD | $1.97M 2.15M USD | 0 | -$1.21 -1.3 USD | |
| BioSenic S.A. BT1.F | $0.001799 0.0019 USD |
-25
|
$1.37M 1.5M USD | $211K 230.65K USD | $0.001799 0.0019 USD | $0.001799 0.0019 USD | $1.37M 1.5M USD | 0 | -$0.04 -0.04 USD | |
| Novo Nordisk A/S NOVA.F | $68.5 74.88 USD |
-1.3
|
$307.49B 336.13B USD | $4.46K 4.87K USD | $67.5 73.79 USD | $71.8 78.49 USD | $307.49B 336.13B USD | 21.74 | $3.15 3.44 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $394.55 431.3 USD |
+0.86
|
$101.32B 110.76B USD | $2 2.19 USD | $394.55 431.3 USD | $394.55 431.3 USD | $101.32B 110.76B USD | 0 | -$3.27 -3.5 USD | |
| CSL Limited CSJ.F | $132.62 144.97 USD |
-1.03
|
$65.34B 71.42B USD | $50 54.66 USD | $132.56 144.91 USD | $132.62 144.97 USD | $65.34B 71.42B USD | 28.03 | $4.73 5.17 USD | |
| CSL Limited CSJA.F | $66 72.15 USD |
-1.49
|
$65.09B 71.15B USD | $5 5.47 USD | $66 72.15 USD | $66 72.15 USD | $65.09B 71.15B USD | 28.08 | $2.35 2.57 USD | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $258.3 282.36 USD |
+0.94
|
$34.62B 37.85B USD | $30 32.79 USD | $258.3 282.36 USD | $258.3 282.36 USD | $34.62B 37.85B USD | 0 | -$1.81 -1.9 USD | |
| argenx SE 1AEA.F | $498 544.38 USD |
+2.05
|
$31.55B 34.49B USD | $149 162.88 USD | $498 544.38 USD | $498 544.38 USD | $31.55B 34.49B USD | 34.94 | $14.25 15.58 USD | |
| UCB SA UNC0.F | $79 86.36 USD |
-1.25
|
$31.06B 33.96B USD | $50 54.66 USD | $79 86.36 USD | $79 86.36 USD | $31.06B 33.96B USD | 28.83 | $2.74 3 USD | |
| UCB SA UNC.F | $160.85 175.83 USD |
-1.44
|
$31.06B 33.96B USD | $1 1.09 USD | $160.85 175.83 USD | $160.85 175.83 USD | $31.06B 33.96B USD | 29.35 | $5.48 5.99 USD | |
| argenx SE 1AE.F | $508 555.31 USD |
+1.8
|
$31.02B 33.91B USD | $5 5.47 USD | $496.7 542.96 USD | $508 555.31 USD | $31.02B 33.91B USD | 35.97 | $14.12 15.44 USD | |
| BeOne Medicines Ltd. 49BA.F | $234 255.79 USD |
+4.46
|
$27B 29.51B USD | $15 16.4 USD | $234 255.79 USD | $234 255.79 USD | $27B 29.51B USD | 0 | -$3.14 -3.4 USD | |
| BeOne Medicines Ltd. 49B.F | $16.6 18.15 USD |
+0.58
|
$25.73B 28.13B USD | $509 556.41 USD | $16.6 18.15 USD | $16.6 18.15 USD | $25.73B 28.13B USD | 0 | -$0.24 -0.2 USD | |
| BioNTech SE 22UA.F | $91.3 99.8 USD |
-0.33
|
$22.09B 24.14B USD | $2.73K 2.98K USD | $89.9 98.27 USD | $93.45 102.15 USD | $22.09B 24.14B USD | 0 | -$3.19 -3.4 USD | |
| Royalty Pharma plc RPD.F | $29.89 32.67 USD |
+2.96
|
$16.89B 18.46B USD | $15 16.4 USD | $29.89 32.67 USD | $29.89 32.67 USD | $16.89B 18.46B USD | 14.16 | $2.11 2.31 USD | |
| Insmed Incorporated IM8N.F | $82.5 90.18 USD |
-2.94
|
$16.17B 17.67B USD | $124 135.55 USD | $82.5 90.18 USD | $82.5 90.18 USD | $16.17B 17.67B USD | 0 | -$5.12 -5.5 USD | |
| Innovent Biologics, Inc. 6IB.F | $8.75 9.56 USD |
+0.57
|
$14.52B 15.87B USD | $229 250.33 USD | $8.7 9.51 USD | $8.75 9.56 USD | $14.52B 15.87B USD | 0 | -$0.01 -0.01 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $6.1 6.67 USD |
+1.67
|
$12.51B 13.68B USD | $208 227.37 USD | $6.1 6.67 USD | $6.1 6.67 USD | $12.51B 13.68B USD | 32.10 | $0.19 0.21 USD | |
| Incyte Corporation ICY.F | $59.16 64.67 USD |
-0.47
|
$11.45B 12.52B USD | $13 14.21 USD | $59.16 64.67 USD | $59.16 64.67 USD | $11.45B 12.52B USD | 348.00 | $0.17 0.19 USD | |
| United Therapeutics Corporation UTH.F | $242.5 265.09 USD |
-0.7
|
$11.02B 12.05B USD | $35 38.26 USD | $242.5 265.09 USD | $242.5 265.09 USD | $11.02B 12.05B USD | 11.21 | $21.63 23.64 USD | |
| Verona Pharma plc I9SA.F | $81.2 88.76 USD |
+5.18
|
$10.59B 11.58B USD | $29 31.7 USD | $77.2 84.39 USD | $81.2 88.76 USD | $10.59B 11.58B USD | 0 | -$1.72 -1.8 USD | |
| Exelixis, Inc. EX9.F | $35.15 38.42 USD |
-0.68
|
$9.78B 10.69B USD | $30 32.79 USD | $35.15 38.42 USD | $35.15 38.42 USD | $9.78B 10.69B USD | 18.59 | $1.89 2.07 USD | |
| Akeso, Inc. 4RY.F | $10.4 11.37 USD |
-2.8
|
$9.45B 10.33B USD | $532 581.55 USD | $10.4 11.37 USD | $10.5 11.48 USD | $9.45B 10.33B USD | 0 | -$0.07 -0.07 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $48.87 53.42 USD |
-0.77
|
$9.37B 10.24B USD | $200 218.63 USD | $48.87 53.42 USD | $48.87 53.42 USD | $9.37B 10.24B USD | 20.97 | $2.33 2.55 USD | |
| Moderna, Inc. 0QF.F | $23.05 25.2 USD |
-1.91
|
$8.91B 9.74B USD | $446 487.54 USD | $22.84 24.97 USD | $23.48 25.66 USD | $8.91B 9.74B USD | 0 | -$7.53 -8.2 USD | |
| Ascendis Pharma A/S A71.F | $144 157.41 USD |
-2.04
|
$8.91B 9.74B USD | $1 1.09 USD | $144 157.41 USD | $144 157.41 USD | $8.91B 9.74B USD | 0 | -$5.8 -6.3 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| Blueprint Medicines Corporation 2L9.F | $109 119.15 USD |
-0.91
|
$7.13B 7.8B USD | $70 76.52 USD | $108.25 118.33 USD | $109 119.15 USD | $7.13B 7.8B USD | 0 | -$2.17 -2.3 USD | |
| Bio-Techne Corporation TE1.F | $43.4 47.44 USD |
-1.81
|
$6.83B 7.46B USD | $50 54.66 USD | $43.2 47.22 USD | $43.4 47.44 USD | $6.83B 7.46B USD | 60.27 | $0.72 0.79 USD | |
| Roivant Sciences Ltd. 87S.F | $9.5 10.39 USD |
+0.81
|
$6.63B 7.25B USD | $600 655.88 USD | $9.5 10.39 USD | $9.7 10.61 USD | $6.63B 7.25B USD | 0 | -$0.65 -0.7 USD | |
| Revolution Medicines, Inc. 42Z.F | $34.8 38.04 USD |
-0.57
|
$6.52B 7.13B USD | $86 94.01 USD | $34.8 38.04 USD | $34.8 38.04 USD | $6.52B 7.13B USD | 0 | -$3.46 -3.7 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $33.65 36.78 USD |
+0.57
|
$6.51B 7.12B USD | $35 38.26 USD | $33.65 36.78 USD | $33.65 36.78 USD | $6.51B 7.12B USD | 0 | -$3.07 -3.3 USD | |
| Corcept Therapeutics Incorporated HTD.F | $60.68 66.33 USD |
-0.98
|
$6.43B 7.03B USD | $11 12.02 USD | $60.26 65.87 USD | $60.68 66.33 USD | $6.43B 7.03B USD | 61.29 | $0.99 1.08 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $18.4 20.11 USD |
-4.66
|
$6.22B 6.8B USD | $400 437.25 USD | $18.4 20.11 USD | $18.45 20.17 USD | $6.22B 6.8B USD | 0 | -$4.35 -4.7 USD | |
| 3SBio Inc. 83B.F | $2.58 2.82 USD |
+0.78
|
$6.08B 6.64B USD | $1.82K 1.99K USD | $2.58 2.82 USD | $2.58 2.82 USD | $6.08B 6.64B USD | 25.80 | $0.1 0.11 USD | |
| Legend Biotech Corporation 9LB.F | $31.8 34.76 USD |
-2.45
|
$5.85B 6.4B USD | $50 54.66 USD | $31.6 34.54 USD | $32 34.98 USD | $5.85B 6.4B USD | 0 | -$1.02 -1.1 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $47.09 51.48 USD |
+1.23
|
$5.8B 6.34B USD | $40 43.73 USD | $46.57 50.91 USD | $47.09 51.48 USD | $5.8B 6.34B USD | 14.53 | $3.24 3.54 USD | |
| Financière de Tubize SA FTD.F | $125.4 137.08 USD |
-1.88
|
$5.8B 6.34B USD | $70 76.52 USD | $125.4 137.08 USD | $125.4 137.08 USD | $5.8B 6.34B USD | 62.07 | $2.02 2.21 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $255.2 278.97 USD |
-0.35
|
$5.67B 6.19B USD | $20 21.86 USD | $251.8 275.25 USD | $255.3 279.08 USD | $5.67B 6.19B USD | 0 | -$15.39 -16.8 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $93.52 102.23 USD |
-1.56
|
$5.66B 6.19B USD | $7 7.65 USD | $92.98 101.64 USD | $94.94 103.78 USD | $5.66B 6.19B USD | 14.72 | $6.35 6.94 USD | |
| ALK-Abelló A/S 4AJ0.F | $24.5 26.78 USD |
-1.61
|
$5.51B 6.02B USD | $350 382.6 USD | $24.5 26.78 USD | $24.5 26.78 USD | $5.51B 6.02B USD | 43.75 | $0.56 0.61 USD | |
| TG Therapeutics, Inc. NKB2.F | $31.89 34.85 USD |
-0.92
|
$5.06B 5.53B USD | $115 125.71 USD | $31.89 34.85 USD | $31.89 34.85 USD | $5.06B 5.53B USD | 144.93 | $0.22 0.24 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $30.35 33.18 USD |
-2.44
|
$4.88B 5.34B USD | $235 256.89 USD | $30.35 33.18 USD | $30.35 33.18 USD | $4.88B 5.34B USD | 0 | -$2.58 -2.8 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Axsome Therapeutics, Inc. 19X.F | $89.7 98.05 USD |
-4.8
|
$4.42B 4.83B USD | $250 273.28 USD | $89.7 98.05 USD | $89.74 98.1 USD | $4.42B 4.83B USD | 0 | -$4.98 -5.4 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Zai Lab Limited 1ZL.F | $36.2 39.57 USD |
-5.24
|
$3.99B 4.36B USD | $230 251.42 USD | $36.2 39.57 USD | $36.2 39.57 USD | $3.99B 4.36B USD | 0 | -$2.15 -2.3 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $8.8 9.62 USD |
-1.12
|
$3.89B 4.25B USD | $254 277.66 USD | $8.8 9.62 USD | $8.8 9.62 USD | $3.89B 4.25B USD | 25.88 | $0.34 0.37 USD | |
| Genscript Biotech Corporation G51.F | $1.77 1.93 USD |
-4.25
|
$3.89B 4.25B USD | $2.77K 3.03K USD | $1.77 1.93 USD | $1.77 1.93 USD | $3.89B 4.25B USD | 0 | -$0.07 -0.07 USD | |
| Vaxcyte, Inc. 5VA.F | $28.2 30.83 USD |
-3.42
|
$3.84B 4.2B USD | $100 109.31 USD | $28.2 30.83 USD | $28.2 30.83 USD | $3.84B 4.2B USD | 0 | -$3.44 -3.7 USD | |
| Akero Therapeutics, Inc. 0K4.F | $45.8 50.07 USD |
-1.42
|
$3.82B 4.18B USD | $150 163.97 USD | $45.8 50.07 USD | $45.8 50.07 USD | $3.82B 4.18B USD | 0 | -$3.23 -3.5 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Cytokinetics, Incorporated KK3A.F | $29.2 31.92 USD |
+3.55
|
$3.57B 3.9B USD | $150 163.97 USD | $28.2 30.83 USD | $29.2 31.92 USD | $3.57B 3.9B USD | 0 | -$4.6 -5.02 USD | |
| Merus N.V. 2GH.F | $46.6 50.94 USD |
+1.3
|
$3.51B 3.83B USD | $106 115.87 USD | $46.6 50.94 USD | $46.8 51.16 USD | $3.51B 3.83B USD | 0 | -$3.59 -3.9 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $53.5 58.48 USD |
-4.46
|
$3.45B 3.77B USD | $20 21.86 USD | $53.5 58.48 USD | $53.5 58.48 USD | $3.45B 3.77B USD | 0 | -$2.41 -2.6 USD | |
| Krystal Biotech, Inc. 4KB.F | $118.85 129.92 USD |
-0.71
|
$3.43B 3.75B USD | $190 207.7 USD | $118.85 129.92 USD | $119.05 130.14 USD | $3.43B 3.75B USD | 33.10 | $3.59 3.92 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Camurus AB (publ) 7CA.F | $55.5 60.67 USD |
-1.07
|
$3.26B 3.57B USD | $1 1.09 USD | $53.7 58.7 USD | $55.5 60.67 USD | $3.26B 3.57B USD | 66.07 | $0.84 0.92 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $33.4 36.51 USD |
+3.73
|
$3.16B 3.45B USD | $48 52.47 USD | $33.4 36.51 USD | $33.4 36.51 USD | $3.16B 3.45B USD | 0 | -$5.03 -5.4 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $18.52 20.24 USD |
-3.34
|
$3.13B 3.42B USD | $100 109.31 USD | $18.52 20.24 USD | $18.52 20.24 USD | $3.13B 3.42B USD | 15.69 | $1.18 1.29 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $31.48 34.41 USD |
-3.76
|
$3.09B 3.38B USD | $53 57.94 USD | $31.48 34.41 USD | $31.48 34.41 USD | $3.09B 3.38B USD | 0 | -$2.28 -2.4 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $56.05 61.27 USD |
-1.23
|
$2.87B 3.13B USD | $35 38.26 USD | $56.05 61.27 USD | $56.05 61.27 USD | $2.87B 3.13B USD | 20.53 | $2.73 2.98 USD | |
| Viking Therapeutics, Inc. 1VT.F | $24.05 26.29 USD |
-3.41
|
$2.7B 2.95B USD | $180 196.76 USD | $24 26.24 USD | $24.05 26.29 USD | $2.7B 2.95B USD | 0 | -$1 -1.09 USD | |
| Scholar Rock Holding Corporation 2QK.F | $28.2 30.83 USD |
0
|
$2.68B 2.93B USD | $20 21.86 USD | $28.2 30.83 USD | $28.2 30.83 USD | $2.68B 2.93B USD | 0 | -$2.2 -2.4 USD | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $27 29.51 USD |
-1.46
|
$2.57B 2.8B USD | $60 65.59 USD | $27 29.51 USD | $27 29.51 USD | $2.57B 2.8B USD | 0 | -$3.28 -3.5 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $20.5 22.41 USD |
-5.27
|
$2.5B 2.73B USD | $100 109.31 USD | $20.5 22.41 USD | $20.51 22.42 USD | $2.5B 2.73B USD | 15.18 | $1.35 1.48 USD | |
| Ascentage Pharma Group International 36X.F | $6.9 7.54 USD |
+0.73
|
$2.4B 2.63B USD | $174 190.21 USD | $6.85 7.49 USD | $6.9 7.54 USD | $2.4B 2.63B USD | 0 | -$0.16 -0.1 USD | |
| ImmunityBio, Inc. 26CA.F | $2.65 2.89 USD |
-3.18
|
$2.34B 2.55B USD | $1.5K 1.64K USD | $2.65 2.89 USD | $2.7 2.96 USD | $2.34B 2.55B USD | 0 | -$0.49 -0.5 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $27.8 30.39 USD |
0
|
$2.17B 2.37B USD | $10 10.93 USD | $27.8 30.39 USD | $27.8 30.39 USD | $2.17B 2.37B USD | 0 | -$2.78 -3.03 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $40.6 44.38 USD |
+1
|
$2.12B 2.32B USD | $26 28.42 USD | $40.6 44.38 USD | $40.6 44.38 USD | $2.12B 2.32B USD | 0 | -$1.39 -1.5 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $15.76 17.22 USD |
-1.28
|
$2.04B 2.23B USD | $240 262.35 USD | $15.76 17.22 USD | $15.78 17.25 USD | $2.04B 2.23B USD | 0 | -$1.55 -1.6 USD | |
| Bavarian Nordic A/S BV3.F | $24.4 26.67 USD |
+0.99
|
$1.92B 2.1B USD | $1.09K 1.19K USD | $23.27 25.44 USD | $24.68 26.98 USD | $1.92B 2.1B USD | 10.84 | $2.25 2.46 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $13.78 15.06 USD |
-4.17
|
$1.9B 2.08B USD | $80 87.45 USD | $13.78 15.06 USD | $13.78 15.06 USD | $1.9B 2.08B USD | 0 | -$1.07 -1.1 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $97 106.03 USD |
-2.51
|
$1.87B 2.05B USD | $20 21.86 USD | $97 106.03 USD | $97 106.03 USD | $1.87B 2.05B USD | 0 | -$6.29 -6.8 USD | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $8.8 9.62 USD |
-2.68
|
$1.87B 2.05B USD | $190 207.7 USD | $8.8 9.62 USD | $8.81 9.63 USD | $1.87B 2.05B USD | 0 | -$0.22 -0.2 USD | |
| Vericel Corporation ATQP.F | $35.8 39.13 USD |
-6.77
|
$1.85B 2.02B USD | $22 24.05 USD | $35.8 39.13 USD | $35.8 39.13 USD | $1.85B 2.02B USD | 895.00 | $0.04 0.04 USD | |
| Denali Therapeutics Inc. 4DN.F | $12.6 13.77 USD |
-3.6
|
$1.83B 2B USD | $200 218.63 USD | $12.6 13.77 USD | $12.6 13.77 USD | $1.83B 2B USD | 0 | -$2.3 -2.5 USD | |
| Everest Medicines Limited 6HN.F | $5.55 6.07 USD |
-10.48
|
$1.8B 1.97B USD | $212 231.74 USD | $5.55 6.07 USD | $5.55 6.07 USD | $1.8B 1.97B USD | 0 | -$0.39 -0.4 USD | |
| Veracyte, Inc. 12V.F | $22.8 24.92 USD |
-5.79
|
$1.79B 1.95B USD | $1.17K 1.28K USD | $22.8 24.92 USD | $22.8 24.92 USD | $1.79B 1.95B USD | 63.33 | $0.36 0.39 USD | |
| BB Biotech AG BBZA.F | $32.1 35.09 USD |
-0.47
|
$1.76B 1.92B USD | $15 16.4 USD | $31.8 34.76 USD | $32.1 35.09 USD | $1.76B 1.92B USD | 13.15 | $2.44 2.67 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $29.2 31.92 USD |
-0.68
|
$1.71B 1.87B USD | $54 59.03 USD | $29.2 31.92 USD | $29.2 31.92 USD | $1.71B 1.87B USD | 2.93 | $9.95 10.88 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $18.9 20.66 USD |
+0.53
|
$1.7B 1.86B USD | $350 382.6 USD | $18.9 20.66 USD | $18.9 20.66 USD | $1.7B 1.86B USD | 0 | -$3.17 -3.4 USD | |
| Galapagos NV GXEA.F | $24.6 26.89 USD |
+0.82
|
$1.67B 1.83B USD | $4 4.37 USD | $24.6 26.89 USD | $24.6 26.89 USD | $1.67B 1.83B USD | 0 | -$2.73 -2.9 USD | |
| Galapagos NV GXE.F | $24.76 27.07 USD |
+0.08
|
$1.67B 1.83B USD | $100 109.31 USD | $24.4 26.67 USD | $24.76 27.07 USD | $1.67B 1.83B USD | 0 | -$2.73 -2.9 USD | |
|
لا توجد أسهم مفضَّلة
لا توجد لديك أسهم مفضَّلة حتى الآن؛ لذا يُرجى إضافتها إلى المفضَّلة لرؤيتها هنا |
||||||||||